European Medicines Agency Advises Gene Therapy Developers on Regulatory Requirements

The European Medicines Agency (EMA) has issued draft guidance describing the types of evidence developers of gene therapies need to support marketing authorization — saying very small firms, which comprise the majority of this segment, may not be familiar with the regulatory process. [Read more…]